Striving excellence in heart valve disease

www.malagavalve.com

April 04-05, 2014Hotel NH MálagaMálaga, Spain

Prel iminary Program

Conde de Gálvez, 3 · 29017 Málaga, Spaint +34 902 109 657 · f +34 934 592 059malagavalve2014@mondial-congress.comwww.mondial-congress.com

Technical Secretariat

VenueHotel Nh Málaga****San Jacinto, 2 29007 Málaga, SpainTel. +34 952 071 323www.nh-hotels.com

RegistrationVAT included Early, until March 4 Late, from March 5

Regular 300 € 350 €

Resident* 250 € 300 €

(*) Residents have to provide a certificate from his/her PhD supervisor when registering, otherwise Regular Fee will be charged.

Registration form available at6www.malagavalve.com

Registration fee includes4Admission to all scientific sessions and exhibition, documentation, certificate of attendance, coffee breaks and lunch on April 4.

AccommodationThe Organization of the Málaga Valve 2014 has secured, throught the Technical Secretariat, an important number of rooms in the NH Málaga Hotel4* (Congress Venue).

Reservation form available at4www.malagavalve.com

Double room for single use485,80 € / night

Double room4135,30 € / night

Bed, breakfast and VAT included

General Information FacultyA. Berrebi Department of Cardiac Surgery. Institut Mutualiste Montsouris; and Hôpital Européen Georges Pompidou. Paris, France.A. Evangelista Division of Cardiology. Hospital Universitario Vall d’Hebron. Barcelona, Spain.J.J. Gómez-Doblas Department of Cardiology. Hospital Virgen de la Victoria. Málaga, Spain.J.Mª Hernández Interventional Cardiology. Hospital Virgen de la Victoria. Málaga, Spain.B. Iung Department of Cardiology. Bichat-Claude Bernard Hospital. Paris, France.F. Maisano Cardiac Surgery. San Raffaele University Hospital. Milan, Italy.A. Mügge Division of Cardiology. Hospital of the Rurh University. Bochum, Germany.A. Muñoz Interventional Cardiology. Hospital Virgen de la Victoria. Málaga, Spain.P. Perier Cardiac Surgery. Herz-und Gefäss Klinik. Bad Neustadt/Saale, Germany.J.L. Pomar Cardiac Surgery. Instituto Clínico del Tórax. Hospital Clínic. Barcelona, Spain. President of the Society of Heart Valve Disease.C. Porras Cardiac Surgery. Hospital Virgen de la Victoria. Málaga, Spain.J. Rodés-Cabau Interventional Cardiology. Quebec Heart and Lung Institute. Quebec, Canada.A. San Román Division of Cardiology. Instituto de Ciencias del Corazón. ICICOR. Valladolid, Spain.J. Strauch Division of Cardiosurgery and Thoracic Surgery. University Hospital Bergmannsheil. Bochum, Germany.H-J. Schäfers Department of Thoracic and Cardiovascular Surgery. Saarland University Medical Center. Homburg, Germany; and Xanit Hospital Internacional. Málaga, Spain.M. Such Cardiac Surgery. Hospital Virgen de la Victoria. Málaga, Spain.H. Takkenberg Professor of Clinical Decision Making in Cardio-Thoracic Interventions. Erasmus MC. Rotterdam, The Netherlands.E. de Teresa Department of Cardiology. Hospital Virgen de la Victoria. Málaga, Spain.H. Vanermen Cardiovascular and Thoracic Surgery. OLV Clinic. Aalst, Belgium.

Friday, April 4 Saturday, April 508:00 Registration opens

08:30 MITRAL VALVE Moderator4A. Berrebi, France

08:30 What is the patient’s profile for mitral valve repair? Presentation 1 or 2 mini clinical cases H. Vanermen, Belgium

The audience votes08:45 Expert opinion: Clinical and echo evaluation

A. San Román, Spain09:05 Expert opinion: Percutaneous treatment

J.M. Hernández, Spain09:25 Expert opinion: Surgical treatment

H-J. Schäfers, Germany09:45 Expert opinion: New devices?

F. Maisano, Italy10:05 Discussion

10:50 Coffee break at the Exhibition Area

11:20 TRICUSPID VALVE Moderator4H. Vanermen, Belgium

11:20 What is the patient’s profile for tricuspid valve surgery? Presentation 1 or 2 mini clinical cases M. Such, Spain

The audience votes11:35 Expert opinion: Clinical and echo evaluation

A. Berrebi, France11:55 Expert opinion: Long-term medical and

surgical outcome P. Perier, Germany

12:15 Expert opinion: Repair or replacement P. Perier, Germany

12:35 Discussion

13:30 Expert opinion: Long-term survival and quality of life with the various aortic valve options H. Takkenberg, The Netherlands

14:00 CLOSING REMARKS H-J. Schäfers, Germany

Supported by

Sponsored by

Organizing Committee Miguel Such, Spain Eduardo De Teresa, Spain Hans-Joachim Schäfers, Germany Juan José Gómez-Doblas, SpainJosé Luis Pomar, SpainCarlos Porras, Spain

Organizer08:00 Registration opens

08:30 WELCOME AND INTRODUCTION M. Such, H-J. Schäfers and E. de Teresa

08:45 LATE BREAKING NEWS Moderator4E. De Teresa, Spain

08:45 2012 Guidelines: Valvular heart disease. How do they affect our practice? Update in 2014? B. Iung, France

09:05 The future of TAVI: New indications and new devices. J. Rodés-Cabau, Canada

09:25 Are the new anticoagulants a real improvement? J.J. Gómez-Doblas, Spain

09:45 Late breaking news in heart valve disease B. Iung, France

10:05 Discussion

10:45 Coffee break at the Exhibition Area

11:15 AORTIC STENOSIS: PERCUTANEOUS TREATMENT Moderator4J.M. Hernández, Spain

11:15 What is the patient’s profile for TAVI? Presentation 1 or 2 mini clinical cases A. Muñoz, Spain

11:30 Expert opinion: Results TAVI J. Rodés-Cabau, Canada

11:50 Expert opinion: Complications. AV block. Do residual leaks matter? A. Mügge, Germany

12:10 Expert Opinion: MIS experience with rapid deployment valves J. Strauch, Germany

12:30 Discussion

13:30 Lunch

15:00 AORTIC REGURGITATION Moderator4J.L. Pomar, Spain

15:00 What is the patient’s profile for repair? Presentation 1 or 2 mini clinical cases C. Porras, Spain

The audience votes15:15 Expert opinion: Sizing of the aorta.

Do details of the imaging technique matter? A. Evangelista, Spain

15:35 Expert opinion: Treatment options in AR/Guidelines. H-J. Schäfers, Germany

15:55 Discussion

16:45 CLOSING REMARKS J.L. Pomar, Spain